Implementing nationwide measles supplemental immunization activities in Ethiopia in the context of COVID-19: process and lessons learntProject Evaluation Published on 2020-11-162022-10-28 Journal: The Pan African Medical Journal [Category] COVID-19, MERS, [키워드] activity Africa agency antigens approach Committee Community contributed Control coordination Coverage COVID COVID-19 COVID-19 pandemic Decline dose Ethiopia Follow-up immunization implementation Implementing increased the risk measles Measures Modification National outbreak Outbreaks pandemic prevention reached resource risk supplemental immunization activity vaccination Vaccine [DOI] 10.11604/pamj.supp.2020.37.1.26614 PMC 바로가기 [Article Type] Project Evaluation
Recommendations for the Diagnosis, Prevention, and Control of Coronavirus Disease-19 in Children—The Chinese PerspectivesPediatrics Published on 2020-11-052022-10-31 Journal: Frontiers in Pediatrics [Category] COVID-19, [키워드] Analysis board children China Chinese Committee consensus recommendations Control COVID-19 COVID-19 outbreak COVID-19 patient diagnosed Diagnosis editorial fatality guidelines infecting journal management MERS coronavirus Outbreaks pandemic (COVID-19) Patient patients pediatric Pediatric patient pediatrics physician prevention recommendation SARS-CoV-2 severe pneumonia Society [DOI] 10.3389/fped.2020.553394 PMC 바로가기 [Article Type] Pediatrics
BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trialCOVID-19에 대한 타고난 면역 반응을 개선하기 위해 브라질에서 의료 종사자의 BCG 재접종: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2020-10-262022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] accompany activate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Admission Antibiotics antiviral immune response approved assigned Autoimmune Autoimmune diseases Bacillus BCG BCG revaccination BCG vaccination bcg vaccine blinded Blinding block blocks both groups Brazil Breastfeeding carried CFU Characteristics Chemotherapy childhood city clinical trial Committee Comorbidities Comorbidity confirmation Contact contact with control group Coronavirus-2 COVID-19 COVID-19 patient COVID-19 severity COVID-19 symptoms COVID-19 test cross-protection determined by diagnosed direct contact disease disease severity Diseases dissemination dose doses Effectiveness element elicited eligibility criteria Fever health worker health workers healthcare providers HIV hospital Hypothesis ICU identification number IgG and IgM IgM and IgG IgM test immunosuppressive IMPROVE in both group incidence incidence of COVID-19 Inclusion inclusion criteria India induce Infection infections information innate immune response investigator Laboratory lateral flow less macrophages medication meet memory monocyte Monocytes Mortality naso-oropharyngeal swab neutrophil Neutrophils NK NK cell number Nurses objective Open-label outcome outcomes pandemic parallel-group participant physiotherapists platform presenting Prevent Primary outcome Primary outcomes professional protocol randomisation randomised randomised controlled trial randomization Randomized receive recruit recruitment reduce Registered registration number researcher researchers respiratory revaccination right arm RT-PCR Sample size SARS-CoV-2 scar sealed Secondary objective Secondary objectives secondary outcome severe acute respiratory syndrome Coronavirus severity solid tumour specimen statistical analyses status steroid Study protocol Symptom symptomatic infection the disease the vaccine Trial Trial registration Tuberculosis two groups vaccination Vaccine virus virus infection virus infections was performed website WHO [DOI] 10.1186/s13063-020-04822-0 PMC 바로가기 [Article Type] Letter
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial이중 맹검, 무작위, 위약 대조 임상 3상 임상 시험을 통해 의료 전문가를 Sinovac에서 제조한 흡착된 COVID-19(불활성화) 백신으로 치료하는 효과와 안전성을 평가합니다. – PROFISCOV: 무작위 대조를 위한 연구 프로토콜의 구조화된 요약 재판Letter Published on 2020-10-152022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] 95% confidence interval Active surveillance adjuvant Administered administration Adults adverse event adverse events Adverse reaction Adverse reactions age Aluminium aluminium hydroxide Analysis attack rate Beijing blind Blinding Brazil Breastfeeding calculated Care causal relationship China clinical clinical care clinically Committee completion confirmed case Consent consent form Contact contact with Control COVID-19 criterion database defined Diagnosis direct contact disease dissemination dose double-blind double-blind study Efficacy Efficacy and safety elderly element Endpoint evaluate exclusion criteria expected experimental intervention FDA form Frequency genders Health Health Organization hydroxide immunogenicity inactivated Inactivated Vaccines incidence include Inclusion information Informed intramuscular dose life limit Local monitoring multicenter nucleic acid number Nurse Nurses objective Occurrence Older outcome participant Participants Participation Patient phase Phase III Clinical Trial Placebo placebo-controlled clinical trial pregnant pregnant women primary efficacy endpoint produced product professional professionals protocol randomisation randomised randomised controlled trial randomization randomization list randomization system Randomized receive recruitment regimen registry responsible retained Safety Sample size SARS-CoV-2 nucleic acid SARS-CoV-2 virus schedule second vaccination separation Sinovac Sinovac Life Science Sinovac Life Sciences Sponsor status stratified Study protocol subjects symptomatic case symptomatic cases symptomatic individuals systemic adverse reaction systemic adverse reactions the vaccine threshold Trial Trial registration undergo vaccination Vaccine Virological voluntary website World Health Organization [DOI] 10.1186/s13063-020-04775-4 PMC 바로가기 [Article Type] Letter
Interim guidance for health‐care professionals and administrators providing hospital care to adult patients with cognitive impairment, in the context of COVID‐19 pandemicInnovation and Translation Published on 2020-10-132022-10-28 Journal: Australasian Journal on Ageing [Category] Coronavirus, SARS, [키워드] applied behavioural Care Cognitive impairment Committee COVID‐19 COVID‐19 delirium Dementia Developing distress draft engage Escalation group Guidance hospital Interim involved measure mitigate objective pandemic Patient pharmacological physical physical and pharmacological restraints professional psychological symptoms recruited Result resulting risk subgroups Support Symptom [DOI] 10.1111/ajag.12831 PMC 바로가기 [Article Type] Innovation and Translation
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial입원한 COVID-19 환자의 결과 개선에 대한 파모티딘의 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2020-10-132022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] Alanine Alanine transaminase alcoholism All participant All participants allergies allergy allocation approved ARMS aspartate Aspartate transaminase assigned assumption Bandar Abba Bandar Abbas baseline Blinding block randomization blood count Care Chronic kidney disease clearance clinical clinical trial clinical trials code Committee company comparator Comparator group complete blood count concealed control group control groups COVID-19 COVID-19 patient COVID-19 patients creatinine creatinine clearance criteria Dasatinib dialysis discharge dissemination dosage drug therapy electrocardiogram element eligibility criteria End-stage renal disease ethics committee Evidence evidence of excluded expected Famotidine G6PD Glucose Glucose 6 phosphate grouping groups Hepatitis hepatitis C Hospitalized Immunocompromised Immunocompromised patients Infection Intervention Kidney disease Lactate lactate dehydrogenase lead limit Liver disease Local lung infiltration maximum Medical Science Medical Sciences moderate need for dialysis Neratinib normal limit number objective online tool oral contraceptives outcome outcome assessor outcome assessors oxygen oxygen saturation Ozanimod participant Patient patients patients with COVID-19 Pazopanib PCR test pharmaceutical Pharmaceutical Company phosphate Placebo placebo-controlled porphyria positive Pregnancy protocol psoriasis random randomisation randomised randomised controlled trial randomized clinical trial Randomly randomly divided receive recruitment Registered registry renal renal disease renal failure reported Research question researcher respiration rate responsible Rilpivirine Sample size sample size calculation sequence sequence information single-blind Siponimod Standard study drug Study protocol subject submitted technology temperature the ethics committee therapy title Tizanidine transaminase Treatment treatment group Treatment protocol treatment protocols Trial registration two group two groups university Version website were measured written consent [DOI] 10.1186/s13063-020-04773-6 PMC 바로가기 [Article Type] Letter
Role of methemoglobin and carboxyhemoglobin levels in predicting COVID-19 prognosis: an observational studyCOVID-19 예후 예측에서 메트헤모글로빈 및 일산화탄소 헤모글로빈 수치의 역할: 관찰 연구Observational Study Published on 2020-10-012022-09-11 Journal: Medical gas research [Category] MERS, 바이오마커, 임상, [키워드] age approval approved average average age carboxyhemoglobin Chain Reaction Chest Committee computed tomographies Computed tomography consolidation consolidations coronavirus coronavirus disease Coronavirus disease-19 COVID-19 COVID-19 diagnosis COVID-19 prognosis diagnosed with COVID-19 Diagnosis ethical committee Faculty of Medicine females ground-glass appearance had no Health Organization Hospitalised patients Hospitalized information intensive care knowledge Lactate lactate dehydrogenase male methemoglobin nasal no effect no statistically significant difference observational study pandemic pathological findings Patient patients Platelet Platelet count polymerase chain polymerase chain reaction positive Prognosis reverse transcription role significantly lower specimens sputum state hospital statistically statistically significant difference tested the patient Thorax tomography Treatment Turkey university virus was performed World Health Organization [DOI] 10.4103/2045-9912.304224 PMC 바로가기 [Article Type] Observational Study
Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxisCommentary Published on 2020-09-292022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] clinical trial Committee conducted confounders COVID-19 COVID-19 pandemic duplication effort global effort help inefficient monitoring observational studies overcome Prophylaxis question randomized trials Research risk Safety subject Treatment Trial trials Volume [DOI] 10.1186/s13063-020-04754-9 PMC 바로가기 [Article Type] Commentary
Treatment of children with COVID-19: position paper of the Italian Society of Pediatric Infectious DiseaseReview Published on 2020-09-242022-10-29 Journal: Italian Journal of Pediatrics [Category] COVID-19, SARS, [키워드] children Committee connection Consensus COVID-19 Italian paediatrics pediatric SARS CoV-2 Society Treatment treatment strategy [DOI] 10.1186/s13052-020-00900-w PMC 바로가기 [Article Type] Review
COVID-19: A Driver for Disruptive Innovation of the Emergency Medicine Residency Application Process Recommendations from the Council of Residency Directors Application Process Improvement CommitteeEducation Published on 2020-09-192022-10-28 Journal: Western Journal of Emergency Medicine [Category] Coronavirus, MERS, [키워드] activity Affect application change Committee Community component coronavirus disease Council COVID-19 effort Emergency equity improvement Innovation Interaction Medicine pandemic Patient care Process promote [DOI] 10.5811/westjem.2020.8.48234 PMC 바로가기 [Article Type] Education